findmyKOL
Clinical trialNCT00049699CompletedPhase 1Interventional

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

SponsorVion PharmaceuticalsLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale Comprehensive Cancer Center

    New Haven, Connecticut, United States

  • Veterans Affairs Medical Center - West Haven

    West Haven, Connecticut, United States

  • Ireland Cancer Center

    Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2002
Primary completion
Completion
31 Jan 2008
Last update posted
18 Jul 2013
Registered enrollment
Registry id
NCT00049699

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.